BeaconEquity.com: BPAX incurs net loss of $6.4M for quarter ended September 30, 2009

		Cancer Friends Network > Types of Cancer > Vaginal Cancer
BeaconEquity.com: BPAX incurs net loss of $6.4M for quarter ended September 30, 2009

LinkBack

Thread Tools

Display Modes

#1 (permalink)

03-14-2010, 08:41 PM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 84,681

BeaconEquity.com: BPAX incurs net loss of $6.4M for quarter ended September 30, 2009

BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 03:55 AM.